Development of a safer new treatment for Systemic Lupus Erythematosus that preserves B cell immunity [ 2016 - ]

Research Grant

Researchers: Prof Fabienne Mackay (Principal investigator)

Brief description Lupus is an illness characterized by the body’s immune system attacking the body itself. More than 5 millions of people worldwide suffer from lupus, in particular Indigenous Australians who are 4 times more likely to develop lupus. Current treatments are toxic and/or lack efficacy. In this proposal we use strong new evidence from the laboratory to support the design of a much safer and more effective treatment for lupus that will be validated for future use in patients.

Funding Amount $672,008.00

Funding Scheme Development Grants

Notes Development Grant